Note. There has been a correction to the SMH article. Correction is as follows
Correction: An earlier version of the article, with the headline ResMed heart attack trial stopped after putting patients at risk, said ResMed put an early stop to its trial. In fact it had come to completion. The article also said it the trial looked at patients who had previously suffered a heart attack or stroke. In fact it looked at patients who suffered from heart failure.
ResMed heart attack trial stopped after putting patients at risk, page-8
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
